Ocular Changes With Alpha-2 Receptor Agonist.

NCT05670015 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Glaucoma, Suspect
Aberration, Corneal Wavefront

Interventions

DRUG: Low dosage selective alpha-2 receptor agonists topical eyedrop
DRUG: High dosage selective alpha-2 receptor agonists topical eyedrop

Sponsor

Benha University